Overview

Warner Chilcott, now part of Allergan, was known for developing and marketing pharmaceutical products primarily in the women's health and dermatology sectors. As a subsidiary of Allergan, it continues to contribute to the parent company's expansive portfolio in specialty pharmaceuticals.

Therapeutic areas

FDA compliance signals

10 FDA enforcement records linked to this company.

  • 4832016-10-03

    Sampling and testing plans not described

  • 4832016-10-03

    Written distribution procedure

  • 4832016-10-03

    Cleaning SOPs/schedules

  • 4832016-10-03

    SOPs not followed / documented

  • recall — Class II2013-08-07

    Failed Impurities/Degradation Specifications: unspecified degradation product

  • recall — Class III2013-05-08

    Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

  • recall — Class III2013-05-08

    Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

  • recall — Class III2013-05-08

    Chemical contamination: Firm's inspection discovered the presence of 2-phenylphenol in the product due to migration from the cardboard cartons in which the product is packaged.

  • recall — Class III2013-02-06

    Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles

  • recall — Class III2013-02-06

    Failed Impurity/Degradation Specifications due to moisture ingress in individual bottles

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.